The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137070 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Giulia Spagnol und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, Italy. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoadjuvant Therapy, Ovarian Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Immunotherapy, particularly the use of immune checkpoint inhibitors (ICIs), has shown limited efficacy in treating ovarian cancer (OC), possibly due to diverse T cell infiltration patterns in the tumor microenvironment. This review explores how neoadjuvant chemotherapy (NACT) impacts the immune landscape of OC, focusing on tumor-infiltrating lymphocytes (TILs), PD-1/PD-L1 expression, and their clinical implications. A comprehensive literature search across four databases yielded nine relevant studies. These studies evaluated stromal (sTILs) and intra-epithelial (ieTILs) TILs before and after NACT. sTIL responses varied, impacting prognostic outcomes, and ieTILs increased in some patients without clear survival associations. PD-L1 expression after NACT correlated with improved overall survival (OS), and increases in granzyme B+ and PD-1 correlated with longer progression-free survival (PFS). Remarkably, reduced FoxP3+ TILs post-NACT correlated with better prognosis. NACT often increases sTIL/ieTIL and CD8+ subpopulations, but their correlation with improved PFS and OS varies. Upregulation of co-inhibitory molecules, notably PD-L1, suggests an immunosuppressive response to chemotherapy. Ongoing trials exploring neoadjuvant ICIs and chemotherapy offer promise for advancing OC treatment. Standardized measurements assessing TIL density, location, and heterogeneity are crucial for addressing genetic complexity and immunological heterogeneity in OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, Italy.
- Department of Oncology, Lausanne University Hospital, University of Lausanne (UNIL), 1015 Lausanne, Switzerland.
- Lausanne Branch, Ludwig Institute for Cancer Research, University of Lausanne (UNIL), 1015 Lausanne, Switzerland.
- Agora Cancer Research Center, 1005 Lausanne, Switzerland.
- Department of Oncology, Ordine Mauriziano Hospital, University of Turin, 10124 Turin, Italy.
- Istituto Oncologico Veneto IOV-IRCCS, 35128 Padova, Italy.
ORCID-Profile: Giulia Spagnol, Matteo Morotti, Matteo Marchetti, Sofia Bigardi, Carlo Saccardi, Roberto Tozzi, Denarda Dangaj Laniti
Zitieren
APA
Spagnol, G., Ghisoni, E., Morotti, M., De Tommasi, O., Marchetti, M., Bigardi, S., Tuninetti, V., Tasca, G., Noventa, M., Saccardi, C., Tozzi, R., & Dangaj Laniti, D. (2024). The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137070
Vancouver
Spagnol G, Ghisoni E, Morotti M, De Tommasi O, Marchetti M, Bigardi S, et al. The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137070
BibTeX
@article{Spagnol2024,
author = {Spagnol, Giulia and Ghisoni, Eleonora and Morotti, Matteo and De Tommasi, Orazio and Marchetti, Matteo and Bigardi, Sofia and Tuninetti, Valentina and Tasca, Giulia and Noventa, Marco and Saccardi, Carlo and Tozzi, Roberto and Dangaj Laniti, Denarda},
title = {The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137070}
}
EUVIMED